NCT06627426 Virtual Reality for Patient Informed Consent in Neurosurgery
| NCT ID | NCT06627426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | VR-based Informed Consent |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2024-10-22 |
| Primary Completion | 2025-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2024-10-22 with a primary completion date of 2025-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized controlled trial is to evaluate benefits of VR (virtual reality)-based patient informed consent in neurosurgery regarding subjective patient comprehension, patient-doctor relationship and anxiety.
Eligibility Criteria
Inclusion Criteria: * Patients between the age of 18 and 75 * Surgical clipping for intracranial aneurysm, resection of vascular malformations * Craniotomy and Resection of intracranial tumors that can be segmented for VR Exclusion Criteria: * Visual or auditory impairment with no sufficient aid * Patient that had VR informed consent for surgery before * Psychiatric illness, cognitive impairment
Contact & Investigator
Emilia Westarp, Dr.
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT06627426 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying VR-based Informed Consent. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06627426 currently recruiting?
Yes, NCT06627426 is actively recruiting participants. Contact the research team at raphael.guzman@usb.ch for enrollment information.
Where is the NCT06627426 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06627426 clinical trial?
NCT06627426 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Emilia Westarp, Dr. at University Hospital, Basel, Switzerland. The trial plans to enroll 34 participants.